https://twitter.com/HCPLiveNews/status/1720704934444667041An analysis of Target-HTN provides new insight into the effects of lorundrostat among patients with uncontrolled or treatment-resistant hypertension. https://bit.ly/3Mt8AW8 #KidneyWk #Hypertension
— HCPLive (@HCPLiveNews) Nov 4, 2023
No comments:
Post a Comment